Pykus Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series A2
- Investors
-
10
Pykus Therapeutics General Information
Description
Operator of a medical technology company intended to develop biodegradable polymers for unmet needs in vitreoretinal surgery. The company provides a novel biodegradable hydrogel to replace the use of intraocular gas and eliminates the need for retina positioning, enabling surgeons to access material to recover from retina surgery faster and more comfortably.
Contact Information
Website
www.pykustherapeutics.comCorporate Office
- 1000 Massachusetts Avenue
- Suite 101
- Cambridge, MA 02138
- United States
Corporate Office
- 1000 Massachusetts Avenue
- Suite 101
- Cambridge, MA 02138
- United States
Pykus Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A2) | 01-Jul-2024 | Completed | Clinical Trials - Phase 1 | |||
| 7. Later Stage VC (Series A) | 04-Feb-2021 | Completed | Clinical Trials - Phase 1 | |||
| 6. Early Stage VC (Series A) | 11-Jun-2018 | Completed | Clinical Trials - Phase 1 | |||
| 5. Angel (individual) | Cancelled | Clinical Trials - Phase 1 | ||||
| 4. Accelerator/Incubator | 23-May-2017 | Completed | Clinical Trials - Phase 1 | |||
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Grant | 04-May-2016 | $25K | $5K | Completed | Startup | |
| 1. Accelerator/Incubator | 09-Mar-2016 | $5K | $5K | Completed | Startup |
Pykus Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Pykus Therapeutics Patents
Pykus Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12233157-B1 | Hydrogel formulations and methods and devices for administration of the same | Active | 24-Jul-2024 | ||
| WO-2026024285-A1 | Hydrogel formulations and methods and devices for administration of the same | Pending | 24-Jul-2024 | ||
| US-11883378-B2 | Hydrogel formulations and methods and devices for focal administration of the same | Active | 24-Nov-2021 | ||
| US-20230157988-A1 | Hydrogel formulations and methods and devices for focal administration of the same | Active | 24-Nov-2021 | ||
| WO-2023097213-A1 | Hydrogel formulations and methods and devices for focal administration of the same | Inactive | 24-Nov-2021 | A61K31/795 |
Pykus Therapeutics Signals
Pykus Therapeutics Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| SideCar Angels | Angel Group | Minority | ||
| Hongsen Investment | Venture Capital | Minority | ||
| Astellas Venture Management | Corporate Venture Capital | Minority | ||
| Beacon Angels | Angel Group | Minority | ||
| Mass General Brigham Ventures | Venture Capital | Minority |
Pykus Therapeutics FAQs
-
When was Pykus Therapeutics founded?
Pykus Therapeutics was founded in 2016.
-
Where is Pykus Therapeutics headquartered?
Pykus Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Pykus Therapeutics?
Pykus Therapeutics has 8 total employees.
-
What industry is Pykus Therapeutics in?
Pykus Therapeutics’s primary industry is Surgical Devices.
-
Is Pykus Therapeutics a private or public company?
Pykus Therapeutics is a Private company.
-
What is Pykus Therapeutics’s current revenue?
The current revenue for Pykus Therapeutics is .
-
How much funding has Pykus Therapeutics raised over time?
Pykus Therapeutics has raised $11.6M.
-
Who are Pykus Therapeutics’s investors?
SideCar Angels, Hongsen Investment, Astellas Venture Management, Beacon Angels, and Mass General Brigham Ventures are 5 of 10 investors who have invested in Pykus Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process